General Western Blot Reagents
Abcam GR113808, selective 5-HT4 antagonist, 50MG
MW 393.5 g/mol, Purity >99%. Potent, highly selective 5-HT₄ receptor antagonist (pKb = 8.8). Displays > 300-fold selectivity over 5-HT₁A, 5-HT₁B, 5-HT₂A, 5-HT₂C and 5-HT₃ receptors. Decreases water intake and potentiates drinking.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam DNMT Activity Assay Kit (Fluorometric)
DNMT Activity Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam DNMT Activity Assay Kit (Colorimetric)
DNMT Activity Assay Kit (Colorimetric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam E-4031 dihydrochloride, HERG K+ channel blocker, 10MG
MW 474.4 Da, Purity >99%. Type III antiarrhythmic drug that blocks ion channels encoded by the ether-a-go-go related gene (ERG1 or KCNH1). Blocks channels in the open configuration with little effect on the channels in the closed configuration. The IC50 for block of human ERG channels in expression systems is approx. 350 nM.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Citalopram, 5-HT reuptake inhibitor, 25MG
MW 405.3 Da, Purity >98%. Selective serotonin reuptake inhibitor. Antidepressant in vivo. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bafilomycin A1, (V)-ATPase inhibitor, 10UG
MW 622.8 Da. Highly potent, selective vacuolar (V)-ATPase inhibitor (IC₅₀ = 500 pM in chromaffin granule membranes). Induces vacuolar deacidification and promotes apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bafilomycin A1, (V)-ATPase inhibitor, 100UG
MW 622.8 Da. Highly potent, selective vacuolar (V)-ATPase inhibitor (IC₅₀ = 500 pM in chromaffin granule membranes). Induces vacuolar deacidification and promotes apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ALP Assay buffer
ALP Assay buffer
The product is subject to the following: Abcam Restricted Use Statement
Abcam Do x orubicin hydrochloride, Topoisomerase II inhibitor, 10MG
MW 580 Da, Purity >98%. Topoisomerase II inhibitor (IC₅₀ = 100 nM, Hep3B cells). DNA intercalator that prevents synthesis of nucleic acid. Induces apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Acetyl-D-glucosamine, N-Acetyl derivative of glucosamine, 25G
MW 221.21 Da, Purity >98%. Monosaccharide derivative of glucose found in polymers of bacterial cell walls, chitin, hyaluronic acids and various glycans. Used to identify, differentiate and characterize N-acetyl-β-D-hexoaminidase(s).
The product is subject to the following: Abcam Restricted Use Statement
Abcam LM11A-31, nonpeptide p75NTR ligand, 5MG
MW 316.26 Da. Selective nonpeptide p75NTR ligand. Blocks p75-mediated cell death. Promotes neurogenesis and neurite survival. Does not affect NGF binding to TrkA. Shows neuroprotective and neuroregenerative effects *in vivo.* Orally active. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement